GGrantIndex
← Search

TARGETING SPHINGOSINE-1-PHOSPHATE AXIS WITH FTY720/FINGOLIMOD AS A NOVEL THERAPY FOR TRIPLE-NEGATIVE BREAST CANCER AND CHEMOTHERAPY-INDUCED PAIN

$760,585FY2020Defense Health AgencyDOD

Virginia Commonwealth University, Richmond VA

Investigators

View source on USAspending →